In the current month, AMIX has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AMIX average Analyst price target in the last month is 58.800.
Based on analysts' estimates, AMIX EPS is projected to reach -6.195 in FY2027Q2, following reported EPS of -5.018 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -5.02, while Autonomix Medical IncAMIX's earnings per share (EPS) for the previous quarter was USD -4.93. EPS for the next quarter is expected at USD -6.20.